174 related articles for article (PubMed ID: 38478356)
1. Lactate in breast cancer cells is associated with evasion of hypoxia-induced cell cycle arrest and adverse patient outcome.
Liu Y; Suhail Y; Novin A; Afzal J; Pant A; Kshitiz
Hum Cell; 2024 May; 37(3):768-781. PubMed ID: 38478356
[TBL] [Abstract][Full Text] [Related]
2. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
3. Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor.
Sun L; Liu Y; Lin S; Shang J; Liu J; Li J; Yuan S; Zhang L
Acta Oncol; 2013 May; 52(4):842-51. PubMed ID: 23409769
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor-1α (HIF-1α) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions.
Yi T; Papadopoulos E; Hagner PR; Wagner G
J Biol Chem; 2013 Jun; 288(26):18732-42. PubMed ID: 23667251
[TBL] [Abstract][Full Text] [Related]
5. HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.
Shah T; Krishnamachary B; Wildes F; Mironchik Y; Kakkad SM; Jacob D; Artemov D; Bhujwalla ZM
Oncotarget; 2015 Sep; 6(29):28104-19. PubMed ID: 26305551
[TBL] [Abstract][Full Text] [Related]
6. SOX2 promotes hypoxia-induced breast cancer cell migration by inducing NEDD9 expression and subsequent activation of Rac1/HIF-1α signaling.
Wang Y; Bibi M; Min P; Deng W; Zhang Y; Du J
Cell Mol Biol Lett; 2019; 24():55. PubMed ID: 31462898
[TBL] [Abstract][Full Text] [Related]
7. [Impact of hypoxia-inducible factor-1 on tumor invasion and metastasis in breast cancer].
Wang F; Chang MM; Zhao J; Jiang LL; Shi YH
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):99-103. PubMed ID: 21426805
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
10. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α.
Shi L; He C; Li Z; Wang Z; Zhang Q
Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159
[TBL] [Abstract][Full Text] [Related]
11. The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.
Ghattass K; El-Sitt S; Zibara K; Rayes S; Haddadin MJ; El-Sabban M; Gali-Muhtasib H
Mol Cancer; 2014 Jan; 13():12. PubMed ID: 24461075
[TBL] [Abstract][Full Text] [Related]
12. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
13. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
14. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer.
Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X
Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705
[TBL] [Abstract][Full Text] [Related]
15. Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels.
Campbell EJ; Dachs GU; Morrin HR; Davey VC; Robinson BA; Vissers MCM
BMC Cancer; 2019 Apr; 19(1):307. PubMed ID: 30943919
[TBL] [Abstract][Full Text] [Related]
16.
Canales J; Valenzuela M; Bravo J; Cerda-Opazo P; Jorquera C; Toledo H; Bravo D; Quest AF
Front Cell Infect Microbiol; 2017; 7():92. PubMed ID: 28401064
[No Abstract] [Full Text] [Related]
17. Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2.
Hoffmann C; Mao X; Brown-Clay J; Moreau F; Al Absi A; Wurzer H; Sousa B; Schmitt F; Berchem G; Janji B; Thomas C
Sci Rep; 2018 Jul; 8(1):10191. PubMed ID: 29976963
[TBL] [Abstract][Full Text] [Related]
18. Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1α pathways in breast cancer.
Su Q; Wang J; Wu Q; Ullah A; Ghauri MA; Sarwar A; Chen L; Liu F; Zhang Y
Phytomedicine; 2021 Apr; 84():153503. PubMed ID: 33636580
[TBL] [Abstract][Full Text] [Related]
19. A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis.
Jia Y; Guo Y; Jin Q; Qu H; Qi D; Song P; Zhang X; Wang X; Xu W; Dong Y; Liang Y; Quan C
J Exp Clin Cancer Res; 2020 Feb; 39(1):42. PubMed ID: 32093760
[TBL] [Abstract][Full Text] [Related]
20. Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.
Cui XY; Tinholt M; Stavik B; Dahm AE; Kanse S; Jin Y; Seidl S; Sahlberg KK; Iversen N; Skretting G; Sandset PM
J Thromb Haemost; 2016 Feb; 14(2):387-96. PubMed ID: 26598923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
